Studies of astaxanthin in people
22 studies gave astaxanthin to people and measured what changed
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases depressive symptomsHAM-D scores decreased by 10.9% | Randomized trial12 weeks | 100 peopleWomen55–60 yearsMidlife adults; Older adults; Postmenopausal women; Sedentary postmenopausal women with mild-to-moderate depressive symptoms | Explore (New York, N.Y.), Nov 1, 2026 |
no change: Has no effect on HbA1c | Randomized trial8 weeks | 90 peoplewomen30 to 60 years oldWomen with T2DM | Scientific reports, Nov 17, 2025 |
up: Increases ventilatory anaerobic thresholdPLA 66.7 ± 4.7%, AX 73.8 ± 4.7% down: Decreases interleukin-1β | Randomized trialfour weeks | 20 peoplemale34.5 ± 7.4 years oldHealthy, career male firefighters | Journal of the International Society of Sports Nutrition, Nov 20, 2024 |
| Randomized trialeight weeks | 60 peopleWomenage > 35 yearsInfertile patients with POR undergoing ART | Journal of ovarian research, Oct 31, 2024 | |
down: Decreases TNF-alpha no change: Has no effect on C-reactive protein no change: Has no effect on body mass index | Randomized trial8 weeks | 56 peoplewomen18–40PCOS patients | Journal of cellular and molecular medicine, Jul 1, 2024 |
down: Decreases IL-6P < 0.01 up: Improves MII oocyte countP = 0.007 no change: Has no effect on clinical pregnancy | Randomized trial8 weeks | 44 peopleWomenPCOS undergoing ART | Inflammopharmacology, Jun 25, 2024 |
| Randomized trial12 weeks | 68 peopleaged 40 to 65Patients with type II diabetes | EXCLI journal, Apr 25, 2023 | |
down: Decreases low-density lipoprotein-0.33 ± 0.11 mM, P < .05 down: Decreases fibrinogen-473 ± 210 ng/mL, P < .05 | Randomized trial24 weeks | 34 peoplePrediabetes and dyslipidaemia | Diabetes, obesity & metabolism, Apr 20, 2023 |
| Randomized trial12 weeks | 50 peopleWomen20 to 40 years oldInfertile endometriosis patients presenting for ART | Frontiers in endocrinology, Mar 20, 2023 | |
down: Decreases carbohydrate oxidation down: Decreases heart rate-7% no change: Has no effect on fat oxidationp > 0.05 | Trial4 weeks | 19 people27.5 ± 6.3 yearsPatient cohorts | International journal of exercise science, Feb 1, 2023 |
up: Increases walking distance down: Decreases d-ROMs down: Decreases blood lactate | Trial16 weeks | 30 people67 to 94Healthy elderly adults living in nursing homes | International journal of environmental research and public health, Oct 18, 2022 |
down: Decreases glucose no change: Has no effect on HbA1c down: Decreases malondialdehyde-modified low-density lipoprotein87.3 ± 28.6 vs. 76.3 ± 24.6 U/L | Randomized trial12 weeks | 53 peopleHealthy subjects and subjects with prediabetes | Nutrients, Dec 7, 2021 |
no change: Has no effect on muscle endurance up: Improves exercise efficiency | Randomized trial12 weeks | 58 people17 males and 23 femalesbetween the ages of 65 and 82Healthy without serious chronic conditions, able to perform activities of daily living without assistance | Physiological reports, Jun 1, 2021 |
down: Decreases malondialdehydeP < .05 down: Decreases IL-6P < .05 | Randomized trial8 weeks | 44 peopleIn patients with type 2 diabetes mellitus | International journal of clinical practice, Feb 2, 2021 |
| Randomized trial4 weeks | 32 peopleaged from 60 to 70 yearsCaucasian males or females aged from 60 to 70 years seropositive for markers of inflammation and oxidation | The journal of nutrition, health & aging, Jan 1, 2018 | |
down: Decreases visceral body fat massp<0.01 down: Decreases systolic blood pressurep<0.05 | Randomized trial8 weeks | 44 peopleType 2 diabetes mellitus | Asia Pacific journal of clinical nutrition, Jan 1, 2018 |
no change: Has no effect on arterial stiffness+6.0% vs +9.5% placebo | Randomized trial1 y | 61 peopleIn renal transplant recipients | The American journal of clinical nutrition, Dec 16, 2015 |
no change: Has no effect on endurance performancefrom 238 ± 6 to 244 ± 6 W in the ASTA group (P = 0.63) | Randomized trial4 wk | 32 peopleMen25 ± 1 yr | Medicine and science in sports and exercise, Jun 1, 2013 |
down: Decreases LDL cholesterol down: Decreases malondialdehyde | Randomized trial12 weeks | 27 peopleadultWithin the astaxanthin group, compared with baseline | Plant foods for human nutrition (Dordrecht, Netherlands), Nov 1, 2011 |
up: Increases HDL-C down: Decreases triglyceride up: Increases adiponectin | Randomized trial12 weeks | 61 people25-60 yearsMild hyperlipidemia | Atherosclerosis, Oct 14, 2009 |
up: Increases astaxanthin0.032 pmol/L, p < 0.001 down: Decreases hydroxy fatty acidsp = 0.048 and p = 0.047 | Randomized trial3 months | Men19-33 yearsGeneral population; healthy non-smoking | International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, Jan 1, 2007 |
up: Increases LDL oxidation lag time31.5, 45.4, 65.0 min versus control 19.9 min | Trial14 days in volunteers | 24 peoplemean age 28.2 [SD 7.8] yearsCell-free in vitro LDL oxidation induced by 400 microM V-70 | Journal of atherosclerosis and thrombosis, Jan 1, 2000 |